Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double Trigger (GnRH Agonist + hCG) for Oocyte Maturation in IVF
NCT02703584Phase 4Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Mar 2016
- Primary completion
- Sep 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of buserelin in infertility (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Number of mature oocytes (MII). Started Mar 2016; status: completed.
02
Drugs
buserelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02703584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703584.